Case of fulminant type 1 diabetes induced by the anti‐programmed death‐ligand 1 antibody, avelumab.

Autor: Shibayama, Yui1 (AUTHOR), Kameda, Hiraku1 (AUTHOR) hkameda@huhp.hokudai.ac.jp, Ota, Shoichiro2 (AUTHOR), Tsuchida, Kazuhisa1 (AUTHOR), Cho, Kyu Yong1 (AUTHOR), Nakamura, Akinobu1 (AUTHOR), Miyoshi, Hideaki3 (AUTHOR), Atsumi, Tatsuya1 (AUTHOR)
Zdroj: Journal of Diabetes Investigation. Sep2019, Vol. 10 Issue 5, p1385-1387. 3p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje